Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Zentek Ltd. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces Voting Results of Annual and Special Meeting Guelph, ON - October 10, 2023, Zentek Ltd. , an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders held on October 5, 2023. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set out in the Management Information Circular dated August 28, 2023. The Management Information Circular is available on SEDAR+ . Election of Directors All of the board of director nominees listed in the Management Information Circular were elected as directors of the Company. Results of the vote were as follows: Nominee Votes For Francis Dube 95.832% Greg Fenton 95.31..."
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose"
10/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces the Launch of Subsidiary for Aptamer- Based Platform Technology Guelph, ON - October 5, 2023, Zentek Ltd. , an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the rapid-detection platform and the recent aptamer-based platform technology developed by Dr. Yingfu Li and his team that is showing promise as a therapeutic through preclinical studies being conducted by Dr. Matthew Miller and his team. This new entity has been launched as a vehicle to accelerate the growth of the aptamer technology, to communicate the technology to potenti..."
10/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Provides Corporate Update Guelph, ON - October 4, Zentek Ltd.  , a graphene technology development and commercialization company is pleased to provide a corporate update and recap of its ZenGUARD™ commercialisation efforts and other aspects of its operations over the past several months. "Zentek has made significant strides on our ZenGUARD™ platform over the last number of months as we continue to push toward successful commercialization. The top priority is ZenGUARD™, and while the Pest Management Regulatory Agency in Canada reviews our ZenGUARD™-coated HVAC filter product submission, the team is focused on targeting potential customers, distributors and manufacturers in the HVAC space, while also ensuring all internal processes are optimized for a suc..."
08/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Guelph, ON - August 24, 2023, Zentek Ltd. , a graphene technology development and commercialization company has signed a Distribution and Supply Agreement with Henry Schein, Inc. . This initial agreement will be for a period of three years and is for Canada and the United States. Sales of ZenGUARD™ surgical masks in the United States will commence upon facility establishment registration and issuance of market clearance from the Food and Drug Administration. Henry Schein is the world's largest provider of health care solutions to office-based dental and medical practitioners. The Henry Schein team will market and distribute ZenGUARD™ surgical masks to dental practices in the U.S. and Canada. Greg Fenton, CEO of Zentek commented: "Henry Schein has been a leading company in the s..."
08/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Unaudited Condensed Interim Consolidated Financial Statements for the three months ended June 30, 2023",
"Management's Discussion and Analysis For the three-month period ended June 30, 2023",
"Certification of Interim Filings CEO",
"Certification of Interim Filings CFO"
08/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek and McMaster University Announce New Aptamer Technology Platform"
07/24/2023 6-K Quarterly results
07/19/2023 6-K Quarterly results
07/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Guelph, ON - July 13, 2023, Zentek Ltd. , a graphene technology development and commercialization company, is pleased to announce updates to its senior management team. Mr. Colin van der Kuur has been promoted from Vice President, Science and Research to Chief Scientific Officer. Colin has been with Zentek since 2018 and has been instrumental in identifying and helping develop key technologies for the Company and has been integral in the process of securing intellectual property rights for such technologies. Mr. Ryan Shacklock has been promoted to Senior Vice President, Strategy and Business Development. Ryan joined Zentek in 2021 and has successfully assumed and navigated several responsibilities, including business strategy, business development, marketing, investor relations, and govern..."
06/29/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Guelph, ON - June 29, 2023, Zentek Ltd. , a graphene technology development and commercialization company announces the filing of its audited consolidated financial statements for the financial year and quarter ended March 31, 2023 . Over-Impairment of Albany Graphite Project As previously announced in its press release of December 23, 2021, the Company, in connection with a review by Staff of the Ontario Securities Commission, conducted an impairment analysis on its Albany Graphite Project in Northern Ontario and determined at the time that the recoverable amount and carrying value of the Albany Graphite Project as at September 30, 2021 was negligible, and accordingly the value of the asset was impaired to Nil. During the preparation of the 2023 Annual Financial Statements, while reviewin..."
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"About Zentek Ltd. Zentek is an ISO 13485:2016 certified graphene technology company focused on the research, development and commercialization of graphene-based novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. Zentek's patented technology platform ZenGuard, is shown to have 99-per-cent anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGuard production facility is located in Guelph, Ontario. Zentek's patent pending ZenARMOR™ technology platform is focused on corrosion protection applications. For further information: Mitch Swergold Tel: 930-8723 Email: [email protected] Francis Dube Tel: 8..."
05/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces Normal Course Issuer Bid Guelph, Ontario - May 24, 2023 - Zentek Ltd. , announces that, subject to regulatory approval, it will conduct a normal course issuer bid . The Bid will be for up to 4,979,349 common shares of the Company over a period of one year , being approximately 5% of Company's issued and outstanding common shares of the Company's issued and outstanding common shares, with up to 1,991,739 common shares of the Company purchasable over any 30-day period within the Bid Period, being 2% of Company's issued and outstanding common shares. The Bid Period will commence on June 1st , 2023, and will continue until the earlier of May 31st , 2024, or the date by which the Company has acquired the maximum number of common shares which may be purchased under the Bid. Mana..."
05/18/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Receives ISO 13485:2016 Certification Guelph, ON - May 18, 2023, Zentek Ltd. , a graphene technology development and commercialization company has been granted ISO 13485:2016 Quality Management System certification standard by British Standards Institution . The company has also received Medical Device Single Audit Program certificate # 777967. These certifications validate Zentek's robust QMS that can handle all regulated products and demonstrate safety, reliability, and quality. ISO 13485:2016 is an internationally recognized quality standard for the medical device industry that supports the quality of medical device design, development, and production. MDSAP is currently utilized by Canada, the United States, Japan, Australia, and Brazil. Under the supervision of Vivian Martin, D..."
05/04/2023 6-K Quarterly results
05/03/2023 6-K Quarterly results
04/25/2023 6-K Quarterly results
04/17/2023 6-K Quarterly results
04/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Files Patent Applications for ZenGUARD™ in Multiple New Jurisdictions Guelph, ON - April 5, 2023, Zentek Ltd. , a graphene technology development and commercialization company, has filed patent applications for ZenGUARD™ in 47 countries. The examiner for the Patent Cooperation Treaty, the international patent law treaty, that reviewed the ZenGUARD™ patent application opined that it met all 3 requirements to be granted a patent: novelty, an inventive step and industrial applicability. The Company has also been granted a patent for ZenGUARD™ by the Canadian Intellectual Property Office, as previously announced on December 7th , 2022. Examiners in other jurisdictions will use these actions as a basis for their own examinations and granting of patents in their re..."
03/30/2023 6-K Quarterly results
03/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Guelph, ON - March 22, 2023, Zentek Ltd. , an intellectual property development and commercialization company, announces that SGS Standard Technical Services Co. recently conducted tests to determine the extent of the antimicrobial properties and the time required to achieve deactivation of bacteria and virus on ZenGUARD™-coated mask material. "Our goal at Zentek from early on in the pandemic was to create a technology that could improve the health and safety of our valued frontline healthcare workers" said Greg Fenton, CEO of Zentek. "Our patented ZenGUARD™ antimicrobial technology with 99.99% bacterial and viral filtration efficiency brings an added level of protection that doctors, nurses and all frontline healthcare providers deserve. We are excited to bring our unique ZenG..."
03/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Guelph, ON - March 17, 2023, Zentek Ltd. , an intellectual property development and commercialization company, announces its Chief Executive Officer, Greg Fenton, will present at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21, 2023. Mr. Fenton will participate in a virtual fireside chat at 2 p.m. ET. New technology combined with emerging trends in multiple industrial sectors will continue to create both opportunities and challenges for most of the companies participating in Maxim Group's Industrial Tech Virtual Conference. Maxim Group's introductions and panel discussions with company executives will highlight emerging sector trends and margin and revenue opportunities driven by new technol..."
02/13/2023 6-K Quarterly results
02/06/2023 6-K Quarterly results
01/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Signs Distribution Agreement with Southmedic Inc. Guelph, ON - January 19, 2023, Zentek Ltd. , an intellectual property development and commercialization company, has signed a Distribution Agreement with Southmedic Inc. for the distribution of Zentek's patented ZenGUARD™ surgical masks. Under the agreement, Southmedic will be the distributor of ZenGUARD™-enhanced surgical masks to the Canadian hospital, general practitioner, private surgery, long-term care and nursing home markets. Southmedic is one of the largest independent distributors of medical devices in Canada with a dedicated sales team that supports all Canadian hospitals, clinics and private offices coast to coast. Southmedic currently distributes other personal protective equipment products in Canada and has d..."
01/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces Appointment of New Director of Investor Relations Guelph, ON - January 12, 2023, Zentek Ltd. , an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations. Mr. Swergold earned a Bachelor of Arts in Political Science from Columbia University in the City of New York, and a Juris Doctor degree from Emory University School of Law. After practicing law and serving as a research analyst at two investment banks, Mr. Swergold was a Senior Analyst and Portfolio Manager at various hedge funds, focusing on technology and macroeconomic investing. "Mitch's experience investing in technology companies, from early to later stage, makes him an ideal candidate to support Zentek's investor relations function." said Gr..."
01/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Reciprocal Supply Agreement",
"Manufacturing and Supply Agreement"
12/15/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek Announces Successful Phase 2 Results of HVAC Testing Guelph, ON - December 15, 2022, Zentek Ltd. , an intellectual property development and commercialization company, reports, further to its press release of April 11, 2022, the successful completion of Phase 2 HVAC filter testing by the National Research Council of Canada . The Company has received the preliminary report from Phase 2 testing under its Innovative Solutions Canada Testing Stream contract. The report notes a significant reduction in live airborne test organisms with ZenGUARD™ coating applied to standard HVAC filters without modification to existing HVAC systems, with no reduction in air flow rates or increasing energy use. The testing demonstrated a reduction in live airborne bacteriophage surrogate contamination..."
12/08/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Material Change Report"
12/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek's ZenGUARD™ Patent Application Granted by the Canadian Intellectual Property Office Guelph, ON - December 7, 2022 Zentek Ltd. , an intellectual property development and commercialization company, is pleased to announce that on December 6, 2022, it was granted Patent Number 3,152,759 for its ZenGUARD™ technology, "graphene-silver composites and uses for same as an antimicrobial composition." The patent was granted by the Canadian Intellectual Property Office and has a term of 20 years from the filing date, or in this instance, until September 20 th , 2041. This follows the Company's announcement on September 16, 2022, pertaining to the allowance of this patent, applicable to the use of its ZenGUARD™ technology on personal protective equipment and heating, ventilatio..."
10/28/2022 6-K Quarterly results
10/19/2022 6-K Quarterly results
10/05/2022 6-K Quarterly results
09/27/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Zentek's ZenGUARD™ Patent Application Allowed by the Canadian Patent Office Guelph, ON - September 27, 2022, Zentek Ltd. , an intellectual property development and commercialization company, is pleased to announce that on September 16, 2022, it's Canadian patent application directed to its ZenGUARD™ technology, for use on personal protective equipment , and heating, ventilation, and air conditioning , has been allowed by the Canadian Intellectual Property Office including all 54 claims made in the application. Zentek is now working with its IP counsel to map out the strategy to extend patent protection of its commercial rights in all global jurisdictions of interest. "This is tremendous news for our company and shareholders," said Greg Fenton, CEO for Zentek. "Our team has work..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy